Do Payers Pay More If Drug Risks Are Not Disclosed? GSK Seeks Supreme Court Answer
This article was originally published in The Pink Sheet Daily
GlaxoSmithKline petitions court to review third party payers' RICO claims in Avandia litigation; PhRMA cites 'growing torrent' of such suits against drug makers.
Register for our free email digests: